NDMA contamination in metformin: Detection, risks, and best practices

Ellutia, a global leader in nitrosamine analysis, has published a detailed blog post covering a range of topics around N-nitrosodimethylamine (NDMA) impurities in metformin. The article provides invaluable insights for pharmaceutical professionals navigating the challenges of detecting this harmful carcinogen in a medication relied upon by millions for managing type 2 diabetes.

The presence of NDMA in metformin has raised significant safety concerns within the pharmaceutical industry. Regulatory agencies worldwide have implemented stringent guidelines for its detection, emphasising the critical need for reliable testing methods. Ellutia’s latest blog examines the challenges of NDMA contamination, the regulations governing its detection, and the advanced techniques that help ensure compliance and safeguard patient health.

Key highlights of the blog post:

• Understanding NDMA formation: An overview of how NDMA impurities arise in metformin
• Best Practises for controlling Formation: A discussion on the health implications of NDMA exposure and the importance of stringent quality control
• Detection Techniques: An Overview of the different techniques that can be used to test for NDMA in Metformin

“Ensuring the safety of pharmaceutical products is our highest priority,” said Andrew James, Managing Director at Ellutia. “This blog reflects the insights we’ve gained by working closely with customers to address NDMA contamination in metformin, and we’re proud to share this valuable resource with the industry.”

Ellutia’s work in nitrosamine analysis demonstrates its commitment to advancing pharmaceutical safety through innovative technologies and practical expertise. By following the best practices outlined in this blog, companies can take proactive steps to protect their products and strengthen trust with their customers.

Read the full blog post.

Ellutia invites industry professionals, researchers, and regulators to explore this insightful resource and join the conversation on enhancing pharmaceutical safety. To learn about about Ellutia’s range of solutions for nitrosamine analysis in the pharmaceutical industry, visit the website.

More information online